2m 2m 2m 2m 2m 2m 2m
CYTEK BIOSCI (CTKB)
NASDAQ
$4.64+$0.03 (+0.67%)
Price as of Sep 11, 2026 6:19 PM EDT- $599.2MMarket Cap
- 17.01%1-Year Change
- Medical DevicesIndustry
CYTEK BIOSCI (CTKB)
$4.64+$0.03 (+0.67%)
CTKB | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.61 | ||
Change | +$0.08 (+1.77%) | ||
Open | $4.61 | ||
High | $4.64 | ||
Low | $4.49 | ||
Previous Close | $4.53 | ||
Volume | 897,708 | ||
30-Day Average Volume | 817,461 | ||
1-Week Change | -1.91% | ||
1-Month Change | -2.74% | ||
1-Year Change | 17.01% | ||
3-Year Change | -34.14% | ||
5-Year Change | -82.56% | ||
Fundamentals | |||
Shares Outstanding | 130.0M | ||
Total Assets | $446.9M | ||
Market Cap | $599.2M | ||
Enterprise Value | $527.4M | ||
Period: QTR TTM FY | |||
Revenue | $32.6M | ||
Net Income | -$12.2M | ||
Free Cash Flow | -$849,000.00 | ||
EBIT | -$11.6M | ||
EBITDA | -$9.6M | ||
Net Working Capital | $293.6M | ||
EPS | N/A | ||
Enterprise Value/EBITDA | -55 | ||
Enterprise Value/Revenue | 16 | ||
P/B | 2 | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | -706 | ||
Price/Operating Cash Flow | 438 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue